ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh type medulloblastoma development

5th International Conference on Pathology

Xuanming Shi

University of Texas Southwestern Medical Center, USA

ScientificTracks Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681.C1.019

Abstract
Recent large scale genomic studies have classified medulloblastoma into four subtypes: Wnt, Shh, Group 3 and Group 4. Each characterized by specific mutations and distinct epigenetic states. Previously we showed that a chromatin regulator SMARCA4/ Brg1 is required for Gli-mediated transcription activation in sonic hedgehog (Shh) signaling. We report here that Brg1 controls a transcriptional program that specifically regulates Shh type medulloblastoma growth. Using a mouse model of Shh type medulloblastoma, we deleted Brg1 in pre-cancerous progenitors and primary or transplanted tumors. Brg1 deletion significantly inhibited tumor formation and progression. Genome wide expression analyses and binding experiments indicate that Brg1 specifically coordinates with key transcription factors including Gli1, Atoh1 and REST to regulate the expression of both oncogenes and tumor suppressors that are required for medulloblastoma identity and proliferation. Shh type medulloblastoma displays distinct H3K27me3 properties. We demonstrate that Brg1 modulates activities of H3K27me3 modifiers to regulate expression of medulloblastoma genes. Brg1 regulated pathways are conserved in human Shh type medulloblastoma and Brg1 are important for the growth of a human medulloblastoma cell line. Thus, Brg1 coordinates a genetic and epigenetic network that regulates the transcriptional program underlying Shh type medulloblastoma development.
Biography

Xuanming Shi has completed his PhD in 2009 from the University of Rostock, Germany and Postdoctoral studies in 2014 from the University of Texas Southwestern Medical Center. He is an Instructor there after 5 years of Postdoctoral training. He has published papers in PNAS 2011, Nature Communications 2014 and Oncogenesis 2015 about Shh signaling and epigenetic mechanism in medulloblastoma development.

Email: Xuanming.Shi@utsouthwestern.edu

Top